Voir la vidéoWatch the full video
Events

On May 25th, Astellas announces its intended decision to transfer its manufacturing plant and business based in Meppel, the Netherlands to Delpharm. The definitive agreement will be executed after completing works council consultation and local legal and regulatory requirements.
On February 17th, Delpharm finalized the acquisition of Carelide manufacturing site specialized in infusion bags, located in France.

A leading CDMO

Drug developer and Contract manufacturer. With its plants network, Delpharm is in the Top 5 CDMOs Worldwide.

Dosage forms

Delpharm produces most dosage forms; non-sterile and sterile liquids, solids, semi-solids and biotech.

Development & Regulation

A team of experts to support new pharmaceutical products.

100
100

Management ownership 100%

1
1

Turnover billion €

5
5

World Top 5

6000
6000

Headcount

Serialization
Major on going project for Delpharm since 2015, all Delpharm plants already shipping serialized products.
Read more...
Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.
Read more...
Soft gel capsules
Delpharm now offers the manufacturing and packaging of soft gel capsules in Evreux plant and high potent soft gel capsules in Poznań.
Freeze-drying
New dosage form now available at Delpharm plants.

Customer references

Zoetis
Genfit
Bayer
Takeda
Sanofi
Sanionia
Teva
Bracco
Biogaran
Biocodex
Servier
OM Pharma
LFB
Aguettant
Mylan
Urgo
Daiichi-Sankyo
Eisai
Novartis
Sandoz
Merck
GlaxoSmithKline
HRA Pharma
Meda
Boehringer Indelheim
Aurobindo
Cooper
Zentiva